Concepedia

A Phase I trial to evaluate the safety and immunogenicity of WRSs2 and WRSs3; two live oral candidate vaccines against Shigella sonnei

Robert W. Frenck, Shahida Baqar, William Alexander, Michelle Dickey, Monica McNeal, Jill El-Khorazaty, Holly Baughman, Amy Hoeper, Shoshana Barnoy, Akamol E. Suvarnapunya,

Vaccine · 2018 · 44 citations · 23 references

DOIFull text

Open access

Concepts

References

23

Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.

Karen L. Kotloff, Jonathan P. Winickoff, B Ivanoff et al. · PubMed · 1999 · 1.3K citations · Full text

, , +17

Vaccination against Shigellosis with Attenuated <i>Shigella flexneri</i> 2a Strain SC602

Trinka S. Coster, Charles W. Hoge, Lillian L. VanDeVerg et al. · Infection and Immunity · 1999 · 225 citations · Full text

, , +17

Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study

Mark S. Riddle, Robert W. Kaminski, Claudio Di Paolo et al. · Clinical and Vaccine Immunology · 2016 · 142 citations · Full text

, , +17

Phase I Evaluation of Δ <i>virG Shigella sonnei</i> Live, Attenuated, Oral Vaccine Strain WRSS1 in Healthy Adults

Karen L. Kotloff, David N. Taylor, Marcelo B. Sztein et al. · Infection and Immunity · 2002 · 111 citations · Full text

, , +13

Shigella flexneri invasion plasmid antigens B and C: epitope location and characterization with monoclonal antibodies

J.A.N. Mills, Jerry M. Buysse, Edwin V. Oaks · Infection and Immunity · 1988 · 106 citations · Full text

, , +17